Home » Newsletters » BioWorld

BioWorld

April 8, 1992

View Archived Issues

PATENT ON POSITIVE IMAGING TECHNIQUE

CEPHALON LAUNCHES ALS TRIALS

STEM CELL ISOLATION TECHNIQUE

U.K. COMPANY ENTERS U.S. IPO MARKET

PATCH DEVELOPER RAISES $17.5 MILLION

HEMACARE AIDS THERAPY DESIGNATED ORPHAN

DEAL TO DELAY UBS STOCK DISTRIBUTION

MARKET UNDERTOW GRABS BIOTECH STOCKS

OPTIMISM ON CENTOXIN ISN'T UNANIMOUS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...